CClinicalTrials.gg
CompletedNCT02796313NOSHUpdated Oct 2, 2023

Diet Intervention for Hypertension: Adaptation and Dissemination to Native Communities

An interventional study of DASH Groceries + Weekly Sessions and Groceries + Brochure in Hypertension, sponsored by Washington State University. Completed at 4 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-10-02.

Sponsored by Washington State University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
315
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

We will conduct a randomized trial to test our DASH (Dietary Approaches to Stop Hypertension) based intervention in 370 adult American Indians with inadequately controlled systolic blood pressure (≥130 mmHg). Over the 5 years of the project, we will recruit and randomize 200 participants from each of 4 urban sites: two in Washington, one in Oklahoma, and one in South Dakota.

Read the detailed description

All participants complete 3 data collection visits following an over-the-phone eligibility screening call (baseline, week 8, and week 12). Participants will be randomized into either the control group or the intervention group at the baseline visit.

All participants will receive 8 weekly credits for groceries and will be given equipment for monitoring their BP at home. Study staff will help participants place their grocery orders each week, and will collect readings from the home BP monitoring equipment at the same time. This data will be used to understand whether the intervention is effective for controlling BP.

All participants will be encouraged to maintain their regular levels of physical activity and receive treatment as usual from their healthcare providers.

The control group participants will receive an American Heart Association printed brochure about the health benefits of a low-salt diet. All foods will be available to purchase, including those that do not meet the DASH diet guidelines.

The intervention group participants will receive 1 hour of nutritional counseling over the phone and a personalized prescription for the low-salt DASH diet based on estimated calorie needs at baseline, followed by weekly 20-minute phone calls in weeks 1-8 to provide extra support.

The intervention group's food choices will be limited to fresh produce and a pre-determined list of other foods included in the DASH diet. During weekly phone calls, the dietitian will use a structured phone curriculum to discuss in more detail a different component of the DASH diet, followed by goal setting related to that component. Through small goal setting each week, participants will receive ongoing support to improve full adherence to the DASH diet by the end of week 8.

02

Conditions studied

  • Hypertension

Browse trials for

03

In context

Hypertension

6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.

This study's enrollment of 315 is above the median of 90 across 4,995 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

Washington State University is the lead sponsor of 82 studies on the registry; 16 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 3 (43%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Participants must:

  • be at least 18 years old;
  • have had diagnosed hypertension for at least 1 year;
  • be on a stable routine of antihypertensive medications for at least 2 months OR not currently medicated, without anticipated changes for the duration of the study;
  • have systolic BP ≥ 130 mmHg at the past 2 clinic visits and at the screening call;
  • have access to regular medical care and permission from their primary care provider to participate (study staff obtain verbal permission before recruiting participants);
  • be physically and cognitively able to use the home BP monitoring device;
  • be willing and able to follow all other study procedures.

Exclusion criteria

Exclusion Criteria:

People are ineligible if they:

  • experienced incident cardiovascular disease or stroke within the previous 6 months;
  • have a known diagnosis of secondary hypertension (e.g., renal artery stenosis);
  • have a recent history of high blood potassium due to certain medications that can raise potassium levels;
  • have diagnosed Stage 4 or 5 kidney disease;
  • are currently or planning to become pregnant during the course of the study;
  • are participating in another health research study involving hypertension;
  • are receiving treatment for cancer or another serious or terminal medical condition.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
315 participants (actual)

Study arms

  • Experimental
    Intervention Group

    Participants in the intervention group will receive tailored advice on adopting a low-sodium DASH diet, comprising nutritional education and ongoing guidance for purchasing heart-healthy foods, plus a weekly $35 credit for groceries.

    Behavioral: DASH Groceries + Weekly Sessions

  • Active comparator
    Control Group

    Participants in the control group will receive printed educational materials with general information about low-salt diets plus a weekly $35 credit for groceries.

    Behavioral: Groceries + Brochure

Interventions

  • BehavioralDASH Groceries + Weekly Sessions

    Intervention group participants will receive 1 hour of in-person nutritional counseling and a personalized prescription for the low-salt DASH diet based on estimated calorie needs at baseline, followed by weekly 20-minute phone calls in weeks 1-8 to provide extra support.

  • BehavioralGroceries + Brochure

    Control group participants will receive a printed brochure about the health benefits of a low-salt diet. They will place an unrestricted $35 grocery order for 8 weeks.

06

What researchers measure

Primary outcomes

  1. Improved blood pressure

    Systolic blood pressure measurements collected throughout the study.

    Time frame: 12 weeks

Secondary outcomes

  1. Improved urinary sodium/potassium levels

    Measured by 24 hour urine samples collected at 3 time points.

    Time frame: 12 weeks

  2. Improved BMI

    Measured by weight and height. Waist circumference will also be measured.

    Time frame: 12 weeks

  3. Improved blood lipids

    Measured by cholesterol panel at 3 time points

    Time frame: 12 weeks

07

Study locations

4 sites
  • Chickasaw Nation Health Clinic
    Purcell, Oklahoma 73080, United States
  • Avera Research Institute
    Rapid City, South Dakota 57702, United States
  • Seattle Indian Health Board
    Seattle, Washington 98144, United States
  • NATIVE Project
    Spokane, Washington 99201, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 2, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02796313
Lead sponsor
Washington State University
Collaborators
Oklahoma State University
Responsible party
Dedra Buchwald (Professor, Washington State University) — Principal investigator
First posted
Jun 10, 2016
Start date
Nov 17, 2017
Primary completion
Mar 4, 2023
Completion
Mar 4, 2023
Last update
Oct 2, 2023

Study contacts

Dedra Buchwald
principal investigator · Washington State University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion